BULATO, CRISTIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.233
AS - Asia 3.201
EU - Europa 1.587
SA - Sud America 518
AF - Africa 484
Continente sconosciuto - Info sul continente non disponibili 131
OC - Oceania 43
Totale 12.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.813
SG - Singapore 1.034
CN - Cina 538
VN - Vietnam 483
IT - Italia 432
BR - Brasile 311
HK - Hong Kong 310
BD - Bangladesh 173
FI - Finlandia 130
DE - Germania 119
FR - Francia 106
NL - Olanda 105
CA - Canada 102
IN - India 86
GB - Regno Unito 80
PL - Polonia 77
SE - Svezia 76
MX - Messico 51
TR - Turchia 43
ES - Italia 38
JP - Giappone 37
AR - Argentina 36
IQ - Iraq 36
ZA - Sudafrica 36
AT - Austria 32
RU - Federazione Russa 32
PH - Filippine 31
PK - Pakistan 30
UA - Ucraina 29
CO - Colombia 27
IE - Irlanda 27
ID - Indonesia 26
EC - Ecuador 25
EG - Egitto 25
JM - Giamaica 25
SA - Arabia Saudita 25
CR - Costa Rica 24
MY - Malesia 24
CL - Cile 23
NI - Nicaragua 22
PE - Perù 22
HR - Croazia 21
VE - Venezuela 21
DO - Repubblica Dominicana 20
HN - Honduras 20
AZ - Azerbaigian 19
BJ - Benin 19
JO - Giordania 19
ET - Etiopia 18
KR - Corea 18
LB - Libano 18
AE - Emirati Arabi Uniti 17
CH - Svizzera 17
CI - Costa d'Avorio 17
NP - Nepal 17
PR - Porto Rico 17
CW - ???statistics.table.value.countryCode.CW??? 16
IS - Islanda 16
LC - Santa Lucia 16
LY - Libia 16
PA - Panama 16
BE - Belgio 15
KH - Cambogia 15
MG - Madagascar 15
PY - Paraguay 15
BZ - Belize 14
CZ - Repubblica Ceca 14
GE - Georgia 14
GF - Guiana Francese 14
GR - Grecia 14
IL - Israele 14
LA - Repubblica Popolare Democratica del Laos 14
LV - Lettonia 14
RO - Romania 14
RS - Serbia 14
SN - Senegal 14
TH - Thailandia 14
TJ - Tagikistan 14
TN - Tunisia 14
UY - Uruguay 14
UZ - Uzbekistan 14
XK - ???statistics.table.value.countryCode.XK??? 14
AL - Albania 13
BA - Bosnia-Erzegovina 13
CY - Cipro 13
DK - Danimarca 13
GH - Ghana 13
KE - Kenya 13
MN - Mongolia 13
MU - Mauritius 13
MW - Malawi 13
NO - Norvegia 13
TT - Trinidad e Tobago 13
BF - Burkina Faso 12
GM - Gambi 12
HU - Ungheria 12
IR - Iran 12
KG - Kirghizistan 12
MA - Marocco 12
MD - Moldavia 12
Totale 11.584
Salva come PNG Salva come JPEG
Città #
San Jose 766
Ashburn 726
Singapore 647
Fairfield 499
Woodbridge 339
Chandler 293
Hong Kong 264
Houston 205
Seattle 203
Ann Arbor 179
Cambridge 178
Santa Clara 163
Los Angeles 147
Wilmington 144
Council Bluffs 140
Ho Chi Minh City 136
Beijing 122
Hanoi 104
Boardman 81
Helsinki 79
New York 77
Chicago 65
San Diego 64
Milan 54
Princeton 51
Lauterbourg 50
Des Moines 49
Padova 49
Jacksonville 47
Buffalo 46
Bytom 39
Dallas 39
Dong Ket 37
Medford 37
Munich 36
Villafranca Padovana 32
Rome 30
São Paulo 29
London 27
Orem 25
Phoenix 25
Roxbury 25
Salt Lake City 24
Warsaw 24
Padua 23
Tokyo 23
Da Nang 22
Dublin 21
San José 21
Vienna 21
Brooklyn 20
Managua 20
Toronto 20
Baku 19
Cotonou 19
Denver 19
Guangzhou 19
Hefei 19
Naples 19
Frankfurt am Main 18
Montreal 18
Addis Ababa 17
Haiphong 17
Abidjan 16
Amman 16
Amsterdam 16
Nuremberg 16
Tampa 16
Antananarivo 15
Chennai 15
Johannesburg 15
Panama City 15
Rio de Janeiro 15
Atlanta 14
Castries 14
Dakar 14
Lappeenranta 14
Nanjing 14
Tashkent 14
Accra 13
Dushanbe 13
Nairobi 13
Reykjavik 13
Stockholm 13
Ulan Bator 13
Vientiane 13
Willemstad 13
Bamako 12
Bridgetown 12
Cayenne 12
Elk Grove Village 12
Phnom Penh 12
Quito 12
The Dalles 12
Ankara 11
Baghdad 11
Brasília 11
Cairo 11
Kampala 11
Kingston 11
Totale 7.264
Salva come PNG Salva come JPEG
Nome #
Dynamics of circulating microparticles in obesity after weight loss 347
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 318
X-linked thrombophilia with a mutant factor IX (factor IX Padua). 317
The thioredoxin specificity of Drosophila GPx: A paradigm for a peroxiredoxin-like mechanism of many glutathione peroxidases 306
Effects of long-term administration of recombinant human protein C in xenografted primates. 284
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 271
Direct Oral Anticoagulants in Patients With Inherited Thrombophilia and Venous Thromboembolism: A Prospective Cohort Study 265
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 265
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study 259
Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study 258
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 250
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 245
Peculiar laboratory phenotype/ genotype relationship due to compound inherited protein C defects in a child with severe venous thromboembolism 242
Partial F8 gene duplication (Factor VIII Padua) associated with high factor VIII levels and familial thrombophilia 241
Effect of mercury on selenium utilization and selenoperoxidase activity in LNCaP cells 239
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 232
Thrombin generation in patients with COVID-19 with and without thromboprophylaxis 226
Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis 226
Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S 225
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 217
Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19 214
Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency 213
Platelet factor V levels in moderate to severe congenital factor V deficiency. 207
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 206
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 203
Characterisation of the serotonin efflux induced by cytosolic Ca2+ and Na+ concentration increase in human platelets 202
New prothrombin mutation (Arg596Trp, Prothrombin Padua 2) associated with venous thromboembolism 202
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation 199
Whole blood thrombin generation shows a significant hypo-coagulable state in patients with decompensated cirrhosis 196
Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. 196
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis 194
“In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate 194
Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism. 194
Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death 194
Whole blood rotation thromboelastometry (ROTEM(®)) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V. 192
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 192
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study 190
Thrombin generation and thromboelastometry in monitoring the in-vitro reversal of warfarin: A comparison between 3-factor and 4-factor prothrombin complex concentrates 188
Patients with cirrhosis have a disbalance between coagulation and fibrinolysis resulting in a prothrombotic phenotype 187
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. 186
PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. 185
Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow 184
Thromboelastographic evaluation of coagulative profiles in pig-to-monkey kidney xenotransplantation. 183
Severity of systemic inflammation is the main predictor of ACLF and bleeding in patients with acutely decompensated cirrhosis 182
Crucial roles of red blood cells and platelets in whole blood thrombin generation 179
Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency. 179
Studies on coagulation incompatibilities for xenotransplantation. 175
Endocytosis of exogenous factor V by ex-vivo differentiated megakaryocytes from patients with severe parahaemophilia 171
Reference values for thromboelastometry (ROTEM®) in cynomolgus monkeys (Macaca fascicularis). 168
Cryptogenic ischemic stroke in cardiac transthyretin amyloidosis and sinus rhythm: a case report 161
Thromboelastometry profiles after “in vitro” addition of a new plasma-derived factor V concentrate to whole blood from parahaemophilia patients 160
Genetic modulation of the FV(Leiden)/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes. 151
von Willebrand factor in hospitalized patients with acute decompensation of cirrhosis is increased but not associated with development of ACLF 129
Whole blood coagulation assessment using novel rotational thromboelastometry (ROTEM-R) in seen naive cynomologus monkeys 125
von Willebrand factor does not predict short-term mortality in ACLF 119
Whole blood thrombin generation hypercoagulable profile in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria: a case report 112
Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy 108
Recompensation after acute decompensation in alcohol-related cirrhosis is rare and likely unrelated to platelet-poor plasma thrombin generation and fibrinolysis 103
Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia 53
Extracellular Vesicles Reflect Thrombo‐Inflammatory, Endothelial and Tissue‐Remodelling Changes in Cirrhosis 38
Pathogenic interplay between markedly elevated plasma lipoprotein(a) levels and prothrombotic mechanisms: a case report 32
Increased thrombin generation is linked to first hepatic decompensation in patients with compensated cirrhosis 29
Prospective comparison of viscoelastic coagulation monitor (VCM) and rotational thromboelastometry (ROTEM) in the assessment of cirrhosis coagulopathy 29
Whole blood thrombin generation before and after eculizumab in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria 23
Thrombin dynamics and clinical events in cirrhosis: low prothrombin conversion predicts bleeding risk 19
The natural mutation Arg221aTrp in human α-thrombin abrogates physiological Na+ binding and preferentially hinders the protease anticoagulant functions 18
Totale 12.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.424
article - articoli 35.424
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022502 0 0 0 34 32 70 39 62 34 28 68 135
2022/2023553 91 75 7 78 88 82 6 38 61 3 20 4
2023/2024297 11 46 36 35 24 50 20 3 3 16 23 30
2024/20251.405 5 88 68 43 166 39 77 107 123 72 238 379
2025/20266.430 284 408 719 1.019 631 325 933 505 743 348 255 260
2026/2027997 230 319 268 180 0 0 0 0 0 0 0 0
Totale 12.197